• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

More immunotherapy for multiple sclerosis.

作者信息

Hughes R A, Sharrack B

出版信息

J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):239-41. doi: 10.1136/jnnp.61.3.239.

DOI:10.1136/jnnp.61.3.239
PMID:8795592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC486544/
Abstract
摘要

相似文献

1
More immunotherapy for multiple sclerosis.更多用于治疗多发性硬化症的免疫疗法。
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):239-41. doi: 10.1136/jnnp.61.3.239.
2
Key issues in the diagnosis and treatment of multiple sclerosis. An overview.多发性硬化症诊断与治疗的关键问题。综述。
Neurology. 2002 Sep 24;59(6 Suppl 3):S1-33. doi: 10.1212/wnl.59.6_suppl_3.s1.
3
To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.治疗还是不治疗：特发性单症状脱髓鞘综合征的治疗困境
Arch Neurol. 2000 Jul;57(7):930-2. doi: 10.1001/archneur.57.7.930.
4
The role of magnetic resonance imaging studies in multiple sclerosis.磁共振成像研究在多发性硬化症中的作用。
J Neurosci Nurs. 1998 Oct;30(5):290-301. doi: 10.1097/01376517-199810000-00004.
5
A 29-year-old man with multiple sclerosis.
JAMA. 1998 Oct 28;280(16):1432-9. doi: 10.1001/jama.280.16.1432.
6
[Multiple sclerosis (MS), an inflammatory or degenerative disease?].
Presse Med. 2004 Feb 14;33(3):151-2. doi: 10.1016/s0755-4982(04)98510-7.
7
Options for multiple sclerosis therapy.
JAMA. 1994 Nov 9;272(18):1393.
8
New treatments for multiple sclerosis.多发性硬化症的新疗法。
BMJ. 1995 Feb 11;310(6976):345-6. doi: 10.1136/bmj.310.6976.345.
9
Combination therapy in multiple sclerosis.多发性硬化症的联合治疗
Curr Neurol Neurosci Rep. 2005 May;5(3):245-8. doi: 10.1007/s11910-005-0053-9.
10
[Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept].[多发性硬化症免疫治疗的可能性与局限性。该疾病的炎症和退行性方面需要一个新的发病机制概念]
Nervenarzt. 2003 Jun;74(6):537-8; discussion 539. doi: 10.1007/s00115-003-1523-4. Epub 2003 May 14.

引用本文的文献

1
Intravenous immunoglobulins for multiple sclerosis.用于治疗多发性硬化症的静脉注射免疫球蛋白
Cochrane Database Syst Rev. 2003;2003(4):CD002936. doi: 10.1002/14651858.CD002936.
2
Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts.复发缓解型多发性硬化症治疗试验中的残疾结局指标：安慰剂队列中疾病进程异质性的影响
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):450-7. doi: 10.1136/jnnp.68.4.450.
3
Randomised, double blind, placebo controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves.通过残疾/时间曲线下面积分析干扰素β-1a治疗复发缓解型多发性硬化症的随机、双盲、安慰剂对照研究。
J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):451-6. doi: 10.1136/jnnp.67.4.451.
4
"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis.用于评估复发缓解型多发性硬化症治疗试验结果的“汇总测量”统计量。
J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):726-9. doi: 10.1136/jnnp.64.6.726.

本文引用的文献

1
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.多发性硬化症临床试验中的疗效评估：批判性分析
Mult Scler. 1995 Apr;1(1):37-47. doi: 10.1177/135245859500100107.
2
Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.干扰素β-1b治疗继发进展型多发性硬化症——临床试验概述
Mult Scler. 1995;1 Suppl 1:S51-4.
3
Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.重组人干扰素β治疗复发缓解型和继发进展型多发性硬化症。
Mult Scler. 1995;1 Suppl 1:S48-50.
4
Clinical scales for multiple sclerosis.多发性硬化症的临床量表
J Neurol Sci. 1996 Jan;135(1):1-9. doi: 10.1016/0022-510x(95)00261-y.
5
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.重组人干扰素β-1a治疗复发缓解型多发性硬化症的短期磁共振成像变化研究
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):251-8. doi: 10.1136/jnnp.61.3.251.
6
The treatment of chronic progressive multiple sclerosis with cladribine.用克拉屈滨治疗慢性进行性多发性硬化症。
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1716-20. doi: 10.1073/pnas.93.4.1716.
7
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).肌肉注射干扰素β-1a治疗复发型多发性硬化症的疾病进展。多发性硬化症协作研究组（MSCRG）。
Ann Neurol. 1996 Mar;39(3):285-94. doi: 10.1002/ana.410390304.
8
Assessment of quality-of-life outcomes.生活质量结果评估。
N Engl J Med. 1996 Mar 28;334(13):835-40. doi: 10.1056/NEJM199603283341306.
9
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.多发性硬化症治疗监测中磁共振技术使用指南。美国国家多发性硬化症协会特别工作组。
Ann Neurol. 1996 Jan;39(1):6-16. doi: 10.1002/ana.410390104.
10
MRI dynamics of brain and spinal cord in progressive multiple sclerosis.进展性多发性硬化症中脑和脊髓的磁共振成像动力学
J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):15-9. doi: 10.1136/jnnp.60.1.15.